Baidu Video completed its B round of financing with the support from institutional investors including Houze Ruyi, Jadex Capital, and Gfund Management. The lead investor was Baidu and the total investment volume was USD 100 million. CEC Capital served as
On the evening of July 3, 2018, Shengxunda (300518.SZ) announced its decision to take a 67% stake in TopFun Technology Co., Ltd. (TopFun) for RMB 502.5 million. On July 20, 2018, the acquisition was approved by the shareholders. CEC Capital served as the
The online platform for used cars, Mychebao, announced today that it completed its D round of financing, raising RMB 800 million. Green Harbor Investment was the lead investor and the follow investors included Pacific Alliance Group (PAG), Addor Capital,
Pioneer of the 3D printed pharmaceutical industry, Nanjing Triastek Pharmaceutical Technology Co., Ltd. (also known as “Triastek”), recently raised RMB 100 million, completing its A round of financing. The lead investor was Morningside Venture Capital and the follow investors were Volcanics Ventures and InnoVision Capital. CEC Capital served as the sole financial adviser to CMLabs during this round of financing.
Leading third-party medical testing service provider, Chain Medical Labs (CMLabs), recently announced that it raised hundreds of millions of RMB and the completed its latest B round of financing. The co-lead investors were C-Bridge Capital and Huatai Ruih
AutocloudPro, an auto parts supply chain service company, announced that it had completed Series C financing of RMB 500 million. The round was led by UCAR Capital. This was one of the largest capital raises in the industry.
April 25, 2018- RENRENCHE.COM, a leading Chinese trading platform for used cars, announced that it had completed a new round of financing in the amount of $300 million. The round was led by Goldman Sachs’SSG group, with participation from Tencent and Didi, two internet behemoths in China. CEC Capital served as the Exclusive Financial Advisor to RENRENCHE in this transaction.
Innovative Cellular Therapeutics (ICT) announced that the company had completed its Series B financing of RMB 180 million. Investors in this new round included Volcanics Venture, GTJA Investment Group, SBCVC, Dunhou Capital and Withtruth Capital. The com
EYEGOOD OPHTHALMIC, chain brand of domestic leading ophthalmic hospital, announced that the company has completed $40 million series B financing led by CDH Investments. This is a new round of financing after series A by OrbiMed in 2015.